Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Dec 11, 2017
- Gilteritinib combined with intensive chemotherapy was well-tolerated in newly diagnosed AML patients -
-
-
Nov 30, 2017
- Accelerating the Discovery and Development of Novel Drugs that Target Mitochondrial Functions -
-
Nov 28, 2017
- A breadth of abstracts highlighting the acute myeloid leukemia treatment landscape, healthcare resource use and cost of care to be presented during oral and poster sessions -
-
-
Nov 15, 2017
- Grand Prize winner Hernâni Oliveira of Porto, Portugal will receive a $50,000 grant from Astellas plus a one-year nights and weekends membership to MATTER, a healthcare innovation community -
-
-
Nov 8, 2017
ADC Combination Study Focuses on First-Line Treatment
-
Nov 1, 2017
James Miteff and Gregory Apostol promoted to key national leadership roles.
-
-
-
-
Oct 24, 2017
In the challenge's second year, five entrants will compete for a chance to win a Grand Prize of $50,000 from Astellas and a consultation with Robert Herjavec, star of ABC's Emmy Award-winning hit television show, Shark Tank
-
-
-
Oct 10, 2017
Solid Tumor Antibody-Drug Conjugate (ADC) Enfortumab Vedotin to be Evaluated as a Monotherapy in Patients Previously Treated with a Checkpoint Inhibitor
-
-
Sep 26, 2017
Astellas ranked in recognition of its commitment and support for working mothers
-
Sep 14, 2017
- Enzalutamide is the first androgen receptor-inhibitor to demonstrate a statistically significant improvement in metastasis-free survival (MFS) in this patient population in a randomized, controlled clinical trial
-
Sep 12, 2017
If approved, the combination therapy could potentially offer a new treatment option for patients whose overactive bladder symptoms are not adequately controlled on monotherapy
-
Sep 6, 2017
Winner will attend live taping of ABC's "Dancing with the Stars"
-
Aug 31, 2017
For the third consecutive year, the pharmaceutical company was named to the 2017 Great Place to Work® ranking among medium-sized multinational businesses across all industries in the country
-
-
-
Aug 2, 2017
Moyra Knight, Andrew Lewis and Karl Uhlendorf named to key roles
-
-
Jul 26, 2017
Astellas to Retain Certain Promising Antibody-Drug Conjugate R&D Programs of Agensys
-
-
Jul 19, 2017
Astellas recognized by Great Place to Work® Institute
-
-
-
Jul 12, 2017
David Musselman and Lynn Gerber named to key regional sales roles
-
Jul 6, 2017
Initiative part of Astellas’ ongoing commitment to communities, veterans and their families through its Living Smart social responsibility platform
-
-
Jun 26, 2017
Caroline Walkinshaw and Jacquelyn Bonnell named to key global and regional senior roles
-
Jun 22, 2017
Data Supported Initiation of Currently Enrolling Pivotal Phase 3 ADMIRAL Trial
-
Jun 20, 2017
The challenge is open to nearly anyone with a tangible, unique idea to improve cancer care
-
Jun 19, 2017
Employees also raised nearly $60K at Second Annual “One Astellas Spirit Run”
-
Jun 9, 2017
- Amendment accelerates anticipated PROSPER top-line results by two years -
-
-
Jun 5, 2017
-Pivotal Monotherapy Phase 2 Trial Initiation Planned for 2017-
-
-
-
-
-
-
-
-
-
May 10, 2017
- Decision follows recommendation of Independent Data Monitoring Committee -
.svg)
